Skyscape Web Viewer : Fischbach's Manual of Laboratory and Diagnostic Tests : Main Index

View All
Pretest Phase: Elements of Safe, Effective, Informed Care
Prevalence Clinical Value of a Test Grading Guidelines for Scientific Evidence Diagnostic Testing Overview of Laboratory and Diagnostic Testing
Primary septicemic plague infection, diagnosis of
Pregnanetriol, quantitative (24-hour) in urine
Prenatal Diagnosis and Tests of Fetal Well-Being
Prenatal screen (PRESCP)
Preterm labor
Pretest phase
Prion proteins
Privacy Elements of Safe, Effective, Informed Care Throughout the Testing Process Patient's Bill of Rights and Patient Responsibilities Diagnostic Testing Ethics and the Law
Proctosigmoidoscopy
Progesterone drug effects on Progesterone
Progesterone receptor (PR) Breast Biopsy Cytologic and Histologic Studies Histologic (Tissue) Biopsy Studies Cytologic, Histologic, and Genetic Studies Estrogen/Estradiol Receptor (ER), Progesterone Receptor (PR) Histologic (Tissue) Study and DNA Ploidy (Tumor Aneuploidy)
Prognostic markers, tumor Cytologic and Histologic Studies Immunodiagnostic Studies Tumor Markers Cytologic, Histologic, and Genetic Studies Histologic (Tissue) Biopsy Studies Protein Chemistry Testing/Serum Proteins: Acute-Phase Proteins and Cytokines Useful Information from a Single Biopsy Specimen
Prolactin (hPRL) drug effects on Prolactin (hPRL)
Proliferating cell nuclear antigen (PCNA) Cytologic, Histologic, and Genetic Studies Histologic (Tissue) Biopsy Studies Cytologic and Histologic Studies
Proliferative index Cytologic and Histologic Studies Cytologic, Histologic, and Genetic Studies Histologic (Tissue) Biopsy Studies
Prone position Administration of Drugs and Solutions Intratest Phase: Elements of Safe, Effective, Informed Care Positioning for Procedures Diagnostic Testing Management of Environment Presence of Family or Significant Others
Prophylactic antifungals Safe Practice Domains for Specific Situations Standard Precautions for Prevention and Control of Infection
Prophylactic anti-infectives Safe Practice Domains for Specific Situations Standard Precautions for Prevention and Control of Infection
Prostaglandins, as tumor markers
ProstaScint imaging Prostascint Imaging Overview of Monoclonal Antibody Tumor Imaging
Prostate biopsy Cytologic and Histologic Studies Sentinel Node Location Before Biopsy (Breast, Melanoma) Cytologic, Histologic, and Genetic Studies Histologic (Tissue) Biopsy Studies
Prostate cancer oncoprofile in nuclear medicine study in tumor markers in
Prostate-specific antigen (PSA) Goals of Test Selection with Examples Suggested Age-Specific Prostate-Specific Antigen (PSA) Reference Ranges Prostate-Specific Antigen (PSA) Tumor-Specific and Tumor-Associated Agents
Prostate ultrasound
Prostatic acid phosphatase (PAP) Tumor-Specific and Tumor-Associated Agents Acid Phosphatase; Prostatic Acid Phosphatase (PAP)
Protamine sulfate test Fibrin Monomers (Protamine Sulfate Test; Fibrin Split Products) Tests for Disseminated Intravascular Coagulation (DIC) Blood Studies: Hematology and Coagulation Laboratory Tests to Measure Hemostasis Tests of Hemostasis and Coagulation
Protected health information (PHI) Diagnostic Testing Ethics and the Law Elements of Safe, Effective, Informed Care Throughout the Testing Process Patient's Bill of Rights and Patient Responsibilities
Protein, CSF (total) CSF Total Protein drug effects on